HER2
Clinical trials for HER2 explained in plain language.
Never miss a new study
Get alerted when new HER2 trials appear
Sign up with your email to follow new studies for HER2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat HER2 cancers: brain tumors targeted
Disease control Recruiting nowThis early-stage trial tests a new drug called IAM1363 in people with advanced cancers that have HER2 alterations, including breast, lung, and stomach cancers that have spread to the brain. The study aims to find the safest dose and see if the drug can shrink tumors. About 383 ad…
Matched conditions: HER2
Phase: PHASE1 • Sponsor: Iambic Therapeutics, Inc • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
New pill takes aim at hard-to-treat cancers with HER2 mutations
Disease control Recruiting nowThis early-stage study tests a new drug called CGT4255 in about 100 adults whose advanced solid tumors have certain genetic changes (ERBB2 alterations or HER2 overexpression). The main goals are to check the drug's safety, find the best dose, and see if it shrinks tumors, includi…
Matched conditions: HER2
Phase: PHASE1 • Sponsor: Cogent Biosciences, Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
New hope for hard-to-treat cancers: triple-drug combo targets HER2-positive tumors
Disease control Recruiting nowThis study tests a combination of three drugs (trastuzumab, serplulimab, and chemotherapy) in 20 adults with advanced bile duct or bladder cancers that have stopped responding to standard treatments. The goal is to see if this approach can shrink tumors and improve survival. Part…
Matched conditions: HER2
Phase: PHASE2 • Sponsor: Xiujuan Qu • Aim: Disease control
Last updated Jun 08, 2026 13:17 UTC
-
New hope for hard-to-treat ovarian cancer: targeted drug combo shows promise
Disease control Recruiting nowThis study tests a new drug combination (distamab vedotin plus carboplatin) in 20 people with advanced HER2-positive ovarian cancer who have not had chemotherapy before. The goal is to see if this combo can control the disease longer and with fewer side effects than standard trea…
Matched conditions: HER2
Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated May 29, 2026 14:17 UTC
-
New PET tracer aims to spot Hard-to-Find HER2 cancers
Diagnosis Recruiting nowThis early-phase study tests whether a special radioactive tracer called [68Ga]Ga-ABY-025 can make HER2-positive tumors show up better on PET scans. About 30 adults with advanced or metastatic HER2-positive cancers (like breast, stomach, or head and neck cancer) who are already o…
Matched conditions: HER2
Phase: EARLY_PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis
Last updated Jun 11, 2026 12:10 UTC
-
Italian study tracks rare HER2 mutations in lung cancer patients
Knowledge-focused Recruiting nowThis study is observing people with advanced non-small cell lung cancer (NSCLC) in Italy to find out how often HER2 gene mutations occur and how doctors currently treat these cases. About 50 participants will be followed for one year. The goal is to gather information, not to tes…
Matched conditions: HER2
Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:51 UTC